Issue 84, 2017

Direct sensing of cancer biomarkers in clinical samples with a designed nanopore

Abstract

Here, we show a designed solid-state nanopore sensor for the direct sensing and quantification of prostate-specific antigen (PSA) as cancer biomarker in serum without any pretreatment. This nanopore technique provides a convenient, fast, and low-cost quantification of cancer biomarkers in clinical samples.

Graphical abstract: Direct sensing of cancer biomarkers in clinical samples with a designed nanopore

Supplementary files

Article information

Article type
Communication
Submitted
29 Aug 2017
Accepted
27 Sep 2017
First published
27 Sep 2017

Chem. Commun., 2017,53, 11564-11567

Direct sensing of cancer biomarkers in clinical samples with a designed nanopore

Y. Lin, Y. Ying, X. Shi, S. Liu and Y. Long, Chem. Commun., 2017, 53, 11564 DOI: 10.1039/C7CC06775E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements